Antihyperglycemic effect of puerarin in experimental diabetes mellitus rats

Chinese Pharmaceutical Journal

Volumn 45, Issue 16, 2010, Pages 1242-1246

  Chen, Xiu Fang ^a   Dong, Min ^a   Lei, Kang Fu ^a   Guan, Yu ^a   Jin, Li Qin ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

endorphin; Diabetes mellitus; Glucose transporter 4; Puerarin; Rats

Indexed keywords

AMINOGUANIDINE; BETA ENDORPHIN; GLUCOSE; GLUCOSE OXIDASE; GLUCOSE TRANSPORTER 4; HYPERGLYCEMIC AGENT; INSULIN; INSULIN I 125; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROPYLENE GLYCOL; PUERARIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPOPHYSIS; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MUSCLE CELL; NONHUMAN; PANCREAS; PEPTIDE SYNTHESIS; PEROXISOME; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TISSUE LEVEL; UPREGULATION;

EID: 77956591404     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. BRUNI J F, WATKINS W B, YEN SSC. β-Endorphin in the human pancreas[J]. J Clin Endocrinol Metabol, 1979, 49(4): 649-651.
2. 1-13 in diabetic patients and their relationship With course and severity of the disease[J]. Chin J Endocrinol Metab, 1998, 14 (1): 22-24.
3. CHEN WC, HAYAKAWA S, YAMAMOTO T, et al. Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats [J]. Planta Med, 2004, 70(2): 113-116.
4. CAO L, GU Z L, MAO C P. Effect of puerarin on insulin resistance in diabetic mice [J]. Chin Tradit Herb Drugs, 2006, 37(6): 901-904.
5. RADOSEVICH P M, WILLIAMS P E, MCRAE J R, et al. β-endorphin inhibits glucose production in the conscious dog [J]. J Clin Invest, 1984, 73(4): 1237-1241. (Pubitemid 14132856)
6. CURRY D L, BENNETT L L, LI C H. Stimulation of insulin secretion by beta-endorphin (1-27 and 1-31) [J]. Life Sci, 1987, 40(21): 2053-2058.
7. BAJAJ M, SURAAMORNKUL S, HARDIES L J, et al. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus[J]. Diabetologia, 2007, 50 (8): 1723-1731.
8. XU M E, XIAO S Z, SUN Y H, et al. The study of anti-metabolic syndrome effect of puerarin in vitro [J]. Life Sci, 2005, 77 (25): 3183-3196.
9. ZIEL F H, VENKATESAN N, DAVIDSON M B. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats [J]. Diabetes, 1988, 37(7): 885-890.
10. KARNIELI E, ARMONI M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology [J]. Am J Physiol Endocrinol Metab, 2008, 295 (1): 38-45.
11. HSU F L, LIU I M, KUO D H, et al. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats [J]. J Nat Prod, 2003, 66(5): 788-792. (Pubitemid 36782086)
12. CHENG J T, LIU I M, TZENG T F, et al. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats [J]. Harm Metab Res, 2002, 34(10): 570-576. (Pubitemid 35370366)
13. EVANS A A, SMITH M E. Opioid receptors in fast and slow skeletal muscles of normal and dystrophic mice [J]. Neurosci Lett, 2004, 366(3): 339-341.
14. XIE W, SAMORISKI G M, MCLAUGHLIN J P, et al. Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids [J]. Proc Natl Acad Sci USA, 1999, 96(18): 10385-10390.
15. NILSSON B O. Biological effects of aminoguanidine: an update [J]. Inflamm Res, 1999, 48(10): 509-515.
16. WANG X, DIAO Y, ZHANG H, et al. The role of RAGE in aminoguanidine- induced suppression of venous intimai hyperplasia in diabetic rats [J]. Ann Vasc Surg, 2009, 23(2): 246-254.